🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark Monane

C2N Diagnostics (United States)

ORCID: 0000-0003-1550-4415

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “A polygenic risk score added to a QRISK®2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting”.

A polygenic risk score added to a QRISK®2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting

European Journal of Preventive Cardiology(2024)10.1093/eurjpc/zwae004

N/A

1.3DataRank · unranked

49 citations

Ella Adlen, Mark Monane, Ruth Coll, Sarah Groves, Elizabeth Little +14 more

Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

Nature Reviews Neurology(2024)10.1038/s41582-024-00977-5

N/A

0.843DataRank · unranked

275 citations

Douglas Galasko, Ana C. Pereira, Gil D. Rabinovici, Stephen Salloway, Marc Suárez‐Calvet +30 more

Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid

Alzheimer s & Dementia(2024)10.1002/alz.13764

N/A

0.717DataRank · unranked

118 citations

Kristopher M. Kirmess, Stephanie Eastwood, Traci L. Wente‐Roth, Faith Irvin, Mary S. Holubasch +20 more

Clinical Utility of an Alzheimer’s Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study

Diagnostics(2025)10.3390/diagnostics15020167

N/A

0DataRank · unranked

9 citations

Demetrius M. Maraganore, Robert M. Carlile, Kim G. Johnson, David A. Merrill, Darren R. Gitelman +9 more

Implementation of an Alzheimer’s Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center Study

Journal of Personalized Medicine(2025)10.3390/jpm15100469

N/A

0DataRank · unranked

0 citations

Robert M. Carlile, Kim G. Johnson, Darren R. Gitelman, Lawren VandeVrede, Demetrius M. Maraganore +7 more